Drug Testing Locations - Plains, TX

Drug Testing in Plains, TX

Plains, Texas Statistics

In Plains, TX, Yoakum County reported a 12% increase in drug-related arrests in 2021.

Drug-related emergency room visits in Plains, TX, rose by 8% over the past year according to Yoakum County records.

Yoakum County data shows that 15% of Plains, TX, high school students reported using illicit drugs in 2022.

The rate of opioid prescriptions in Plains, TX, was 72 per 100 residents in 2022, as per Yoakum County health reports.

In 2021, Plains, TX, saw a 10% increase in drug trafficking charges, as per Yoakum County law enforcement data.

Yoakum County reports indicate that 20% of drug-related offenses in Plains, TX, involved methamphetamine in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Plains, TX & Drug Testing Policies

Employers in Plains, TX, have increasingly adopted rigorous drug testing policies to ensure a safe and productive workplace environment. Policies often include pre-employment, random, and post-accident testing. Yoakum County employers are encouraged to use comprehensive testing methods backed by the U.S. Department of Labor guidelines.

Many local companies align their drug testing policies with state standards to maintain a drug-free workplace. Resources available through the Texas Department of Licensing and Regulation provide employers with guidelines to establish effective anti-drug policies in Plains and across Yoakum County.

Government Efforts with Drug Problems in Plains, TX

The city of Plains, TX, in collaboration with Yoakum County, has put forth several initiatives to tackle the drug problem, focusing on prevention and education. The Texas Government has been instrumental in providing resources and support for these local efforts. Additionally, partnerships with the Texas Department of State Health Services ensure comprehensive approaches to combatting drug abuse.

In addition to local initiatives, Plains also benefits from state-funded programs aimed at reducing drug-related harm. These efforts include grants for treatment and prevention spearheaded by the Texas Health and Human Services. Such measures are geared towards reducing the drug burden on communities across Yoakum County.

Local Drug Busts & News in Plains, TX

Recent efforts by law enforcement in Plains, TX, have led to significant local drug busts within Yoakum County. In early 2023, a major operation dismantled a methamphetamine distribution network operating out of Plains. This success highlights the ongoing commitment of the Texas Department of Public Safety in tackling drug-related crimes at the local level.

Public engagement events, such as community forums hosted by the Yoakum County Sheriff's department, focus on the importance of recognizing and reporting drug activities. These initiatives aim to empower Plains residents to play an active role in combating drug abuse, detailing the successes of local busts and preventive strategies.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Plains, TX. Trusted by employers nationwide for accurate results and exceptional service.

Texas DOT/Non DOT Physicals

Texas Vision Tests

Texas Audiograms

Texas Respirator Fit Tests

Texas Lift Tests

Texas Background Checks

Clinical Testing Services

TB Testing in TX

Diabetes Testing in TX

Infectious Disease Testing in TX

Sickle Cell Anemia Testing in TX

Women/Men's Health Testing in TX

Resources & Citations

Texas Drug Support

Yoakum County Health Department

Texas o-drug Response

Texas Stop Drug Abuse

Drug Free Texas

Operation Tantamount

Recovery Texas

Texas Reduction Help

Texas Substance Abuse Services

Texas Community Care

Drug Testing Near Plains, TX

Carbon, TX

Cisco, TX

Thunderbird Bay, TX

May, TX

Putnam, TX

Echo, TX

Romney, TX

Branton, TX

Rising Star, TX

Rowden, TX

Burkett, TX

Cross Cut, TX

Pioneer, TX

Cross Plains, TX

Frequently Asked Questions

Customer Reviews